Polymorphic form X of nilotinib dihydrochloride hydrate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10301282
APP PUB NO 20180111915A1
SERIAL NO

15559325

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel polymorph of nilotinib hydrochloride (Form X), to processes for its preparation, to pharmaceutical compositions containing the same and to its use in medicine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CIPLA LIMITEDMUMBAI 400 013

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chinimilli, Venugopalarao Bangalore, IN 2 13
Gangrade, Manish Gopaldas Mumbai, IN 8 29
Malhotra, Geena Mumbai, IN 171 915
Pathi, Srinivas Laxminarayan Bangalore, IN 39 50
Rao, Dharmaraj Ramachandra Mumbai, IN 111 255

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 28, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 28, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00